Nomura Holdings
WST icon

Nomura Holdings’s West Pharmaceutical WST Stock Holding History

Nomura Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,200
Closed -$9.67M – 2424
2024
Q3 		$9.67M Sell
32,200
-7,800
-20% -$2.39M 0.02% 448
2024
Q2 		$13.2M Buy
+40,000
New +$14.1M 0.03% 377
2024
Q1 		– Sell
-35,000
Closed -$12.3M – 2074
2023
Q4 		$12.3M Buy
+35,000
New +$12.4M 0.03% 387

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's WST Position: Q1 2026 in Review

Nomura Holdings sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 827 shares — an estimated $228K sold.

Nomura Holdings first reported a position in WST in Q1 2014 and held it in 32 quarters. The position peaked at $2.21M in Q3 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Nomura Holdings reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 827 West Pharmaceutical shares in Q1 2026, an estimated $228K.
  • Nomura Holdings first reported a position in West Pharmaceutical in Q1 2014 and held it in 32 quarters.
  • Nomura Holdings's West Pharmaceutical position peaked at $2.21M in Q3 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.